Brief: Nykode Therapeutics Initiates Phase 2 Trial Of Vb10.16
April 19 (Reuters) - Nykode Therapeutics ASA NYKD.OL :
* INITIATES PHASE 2 TRIAL OF VB10.16 IN SECOND LINE
HPV16-POSITIVE
CERVICAL CANCER
Source text for Eikon: ID:nObib1CDga
Further company coverage: NYKD.OL
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Nykode Therapeutics ASA
See all newsRCS - Accession Theraptcs. - Accession Therapeutics: Board appointments
Brief: Nykode Therapeutics Mulls Private Placement
Brief: Nykode Receives Draft Recommendation In Tax Case
Brief: Nykode Therapeutics Receives U.S. Vaccine Patent
Brief: Nykode Therapeutics Expects Draft Recommendation From Norwegian Tax Appeal Board In August 2026